Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Summary: Retatrutide should not be combined with insulin or sulfonylureas without medical supervision, and caution is advised with anticoagulants, narrow therapeutic index drugs, other GLP-1 receptor agonists, and supplements with hypoglycaemic properties
Anyiam O, Phillips B, Quinn K, Wilkinson D, Smith K, Atherton P, et al
Schweitzer PK, Taranto-Montemurro L, Ojile JM, et al
However, long-term human safety data from controlled clinical trials is limited
Importantly, treatment with retatrutide not only resulted in robust weight reduction, but also in clear improvements in assessed cardiometabolic health measures
US$ 21.58
US$ 25.45
US$ 21.38
US$ 21.71
US$ 28.75
US$ 23.67
